Literature DB >> 17551596

Admission is not always necessary for patients with community-acquired pneumonia in risk classes IV and V diagnosed in the emergency room.

T J Marrie1, J Q Huang.   

Abstract

OBJECTIVE: To determine the factors that allow patients with community-acquired pneumonia who are at high risk of mortality (risk classes IV and V) to be treated at home.
DESIGN: A prospective, observational study.
SETTING: Six hospitals and one free-standing emergency room in Edmonton, Alberta. PARTICIPANTS: The present study included 2354 patients in risk classes IV and V who had a diagnosis of pneumonia made by an emergency room physician or an internist. MEASUREMENTS: Symptoms, signs and laboratory findings, as well as outcome measures of length of stay and mortality.
RESULTS: Of the total study group, 319 of the patients (13.5%) were treated on an ambulatory basis. Factors predictive of admission were definite or possible pneumonia on chest radiograph as read by a radiologist, functional impairment, altered mental status, substance abuse, psychiatric disorder, abnormal white blood cell count, abnormal lymphocyte count, oxygen saturation less than 90% and antibiotic administration in the week before admission. If chest pain was present, admission was less likely. Only two of the 319 patients required subsequent admission (both had positive blood cultures) and only two died.
CONCLUSIONS: A substantial number of patients in risk classes IV and V can be safely treated at home. Factors that help clinicians to select this subset of patients are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17551596      PMCID: PMC2676365          DOI: 10.1155/2007/451417

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  7 in total

Review 1.  Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia.

Authors:  Scot H Simpson; Thomas J Marrie; Sumit R Majumdar
Journal:  Respir Care Clin N Am       Date:  2005-03

2.  Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

Authors:  E A Halm; M J Fine; T J Marrie; C M Coley; W N Kapoor; D S Obrosky; D E Singer
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

3.  A prediction rule to identify low-risk patients with community-acquired pneumonia.

Authors:  M J Fine; T E Auble; D M Yealy; B H Hanusa; L A Weissfeld; D E Singer; C M Coley; T J Marrie; W N Kapoor
Journal:  N Engl J Med       Date:  1997-01-23       Impact factor: 91.245

4.  Patients admitted to hospital with suspected pneumonia and normal chest radiographs: epidemiology, microbiology, and outcomes.

Authors:  Sanraj K Basi; Thomas J Marrie; Jane Q Huang; Sumit R Majumdar
Journal:  Am J Med       Date:  2004-09-01       Impact factor: 4.965

5.  Population-based norms for the Mini-Mental State Examination by age and educational level.

Authors:  R M Crum; J C Anthony; S S Bassett; M F Folstein
Journal:  JAMA       Date:  1993-05-12       Impact factor: 56.272

6.  The timed "Up & Go": a test of basic functional mobility for frail elderly persons.

Authors:  D Podsiadlo; S Richardson
Journal:  J Am Geriatr Soc       Date:  1991-02       Impact factor: 5.562

7.  Factors influencing in-hospital mortality in community-acquired pneumonia: a prospective study of patients not initially admitted to the ICU.

Authors:  Thomas J Marrie; Lieling Wu
Journal:  Chest       Date:  2005-04       Impact factor: 9.410

  7 in total
  6 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia.

Authors:  David T Huang; Lisa A Weissfeld; John A Kellum; Donald M Yealy; Lan Kong; Michael Martino; Derek C Angus
Journal:  Ann Emerg Med       Date:  2008-03-17       Impact factor: 5.721

4.  Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

Authors:  Werner C Albrich; Frank Dusemund; Kristina Rüegger; Mirjam Christ-Crain; Werner Zimmerli; Thomas Bregenzer; Sarosh Irani; Ulrich Buergi; Barbara Reutlinger; Beat Mueller; Philipp Schuetz
Journal:  BMC Infect Dis       Date:  2011-05-03       Impact factor: 3.090

Review 5.  Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Dan Liu; Lixin Xie; Haiyan Zhao; Xueyao Liu; Jie Cao
Journal:  BMC Infect Dis       Date:  2016-05-26       Impact factor: 3.090

Review 6.  Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysis.

Authors:  Dan Liu; Long-Xiang Su; Wei Guan; Kun Xiao; Li-Xin Xie
Journal:  Respirology       Date:  2015-12-10       Impact factor: 6.424

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.